Patent Assignment
Reel/Frame 041817/0501
Assignment of Assignor's Interest
Recorded: 2017-02-26
Pages: 48
Assignor
BIOGEN MA INC.
Executed: 2017-01-31
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(2)
Factor Ix Polypeptide Formulations
Patent:
10,588,949 →
Application:
14/776,125 →
Publication:
US 2016/0000888
PCT:
PCT/US2014/029010 ↗
Factor IX-Fc Polypeptide Formulations
Application:
61/794,874 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.